Career guide · Updated August 2026
MSL salary in 2026: what Medical Science Liaisons earn in the US, UK, and Europe
A Medical Science Liaison in the United States earns roughly $130,000 to $235,000 in base salary depending on experience, with a target bonus of 12–20% on top. This guide breaks US MSL pay down by experience level, metro area, therapeutic area, and company type, then covers EU and UK ranges for anyone hiring or moving across regions.
US MSL base (mid-career)
$160k–$195k
Highest-paying US markets
Bay Area · Boston
Top-paying therapeutic areas
Oncology · Rare disease
US MSL salary by experience level
Base and target bonus for full-time field medical roles at US pharma and biotech companies. Total cash excludes equity, which is standard at biotech and increasingly common for senior MSLs at large-cap pharma.
| Role | Base | Target bonus | Total cash |
|---|---|---|---|
| Entry-level MSL (0–2 yrs) | $130k–$160k | 12–15% | $150k–$185k |
| Mid-level MSL (3–6 yrs) | $160k–$195k | 15–18% | $185k–$230k |
| Senior MSL (7+ yrs) | $195k–$235k | 15–20% | $225k–$285k |
| MSL Manager / Field Lead | $220k–$280k | 20–25% | $265k–$350k |
| Medical Advisor | $150k–$190k | 12–18% | $170k–$225k |
| Senior Medical Advisor | $185k–$230k | 15–20% | $215k–$275k |
| Medical Affairs Director | $260k–$330k | 25–30% | $325k–$430k |
US MSL salary by metro area
MSL roles are territory-based, so pay tracks the hiring company's headquarters and the cost of living in your assigned region rather than a single national band.
| Market | Pay index | Notes |
|---|---|---|
| San Francisco Bay Area, CA | +12% vs. national | Deepest biotech cluster; equity-heavy packages. |
| Boston / Cambridge, MA | +10% vs. national | Largest concentration of MSL roles in the US. |
| New York / New Jersey | +8% vs. national | Big-pharma headquarters; strong bonus targets. |
| San Diego, CA | +5% vs. national | Oncology and rare-disease biotech density. |
| Philadelphia, PA | +3% vs. national | Established pharma corridor. |
| Chicago / Midwest territory | national average | Large field territories, more travel. |
| Research Triangle, NC | −2% vs. national | Lower cost of living offsets base. |
| Texas / South territory | −3% vs. national | Wide geographies, no state income tax in TX. |
How therapeutic area changes MSL salary
Therapeutic area is one of the biggest drivers of pay variation inside the same job title. Apply these premiums to the US base ranges above.
MSL pay by company type
MSL salary in Europe and the UK
European and UK base salaries run well below US levels, but packages typically include a company car or allowance, larger pension contributions, and more vacation. Ranges below are indicative annual base salaries at established pharma and biotech companies.
| Role | EU | UK |
|---|---|---|
| Entry-level MSL (0–2 yrs) | €70k–€95k | £60k–£80k |
| Mid-level MSL (3–6 yrs) | €95k–€125k | £80k–£105k |
| Senior MSL (7+ yrs) | €125k–€160k | £105k–£135k |
| MSL Manager / Lead | €140k–€185k | £120k–£160k |
| Medical Advisor | €85k–€120k | £70k–£100k |
| Senior Medical Advisor | €115k–€150k | £95k–£130k |
| Medical Affairs Manager | €135k–€175k | £115k–£150k |
What else affects your MSL offer
- Bonus. 12–20% target for MSLs and Medical Advisors, 20–30% at Manager/Director level.
- Equity / LTI. Standard at biotech, increasingly common at large-cap pharma for senior MSLs.
- Field allowances. Company car or allowance, home-office setup, and travel per diem sit on top of base.
- Territory. National or multi-state territories pay more than single-metro coverage.
- Launch readiness. MSLs joining pre-launch oncology or rare-disease teams often negotiate a sign-on bonus.
- Terminal degree. PharmD, MD, and PhD candidates typically enter at the upper end of the entry-level band.
How to use these numbers in a negotiation
- Anchor your ask to the upper third of the range for your metro, therapeutic area, and seniority.
- Quantify the value you bring, launches supported, KOL relationships, publications, advisory boards.
- Negotiate total package (base + bonus + equity + sign-on), not just base.
- If base is capped, push on sign-on bonus, accelerated review, or additional vacation.
MSL salary FAQ
What is a Medical Science Liaison salary?
In the United States, a Medical Science Liaison typically earns $130,000–$160,000 base at entry level, $160,000–$195,000 mid-career, and $195,000–$235,000 as a senior MSL. Bonus (12–20%) and equity usually add another 10–25% on top of base.
How much does an entry-level MSL make in the US?
Entry-level MSLs with 0–2 years of field experience generally earn $130,000–$160,000 base. PharmD, MD, and PhD candidates joining oncology or rare-disease teams typically start at the upper end of that range.
Do MSLs get bonuses?
Yes. Most US MSL roles carry a target bonus of 12–20% of base, rising to 20–30% at MSL Manager or Director level. Biotechs commonly add stock options or RSUs, and pre-launch teams often include a sign-on bonus.
Which therapeutic area pays MSLs the most?
Oncology and rare disease / cell and gene therapy pay the most, typically 10–25% above the base range for the same seniority, because the required scientific depth narrows the candidate pool.
How much does an MSL Manager or Director make?
US MSL Managers and Leads typically earn $220,000–$280,000 base, and Medical Affairs Directors $260,000–$330,000, before bonus and equity.
Is MSL pay higher in the US than in Europe?
Yes. US MSL base salaries generally run 40–70% above comparable EU roles and 50–80% above UK roles, though European packages often include a company car, larger pension contributions, and more vacation.
Get your personal MSL salary benchmark
The ranges above are a starting point. PharmaReady's interactive Salary Benchmark tool uses your specific therapeutic area, market, seniority, and target company to give you a realistic offer range and a negotiation script, included with the Career Accelerator plan.
Not an MSL yet? Read how to become a Medical Science Liaison →
Disclaimer: salary ranges are estimates based on aggregated Medical Affairs market data as of August 2026 and vary by company, candidate profile, and negotiation. Use as a directional benchmark, not a guarantee.